PYRROLO CARBOXAMIDES AS MODULATORS OF ORPHAN NUCLEAR RECEPTOR RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORy, NR1F3) ACTIVITY AND FOR THE TREATMENT OF CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASES
申请人:PHENEX PHARMACEUTICALS AG
公开号:US20140349987A1
公开(公告)日:2014-11-27
The invention provides modulators for the orphan nuclear receptor ROR
γ
and methods for treating ROR
γ
mediated diseases by administrating these novel ROR
γ
modulators to a human or a mammal in need thereof. Specifically, the present invention provides pyrrolo carboxamide compounds of Formula (1) and the enantiomers, diastereomers, N-oxides, tautomers, solvates and pharmaceutically acceptable salts thereof.
Baur-Thurgau, Chemische Berichte, 1898, vol. 31, p. 1345
作者:Baur-Thurgau
DOI:——
日期:——
PYRROLO CARBOXAMIDES AS MODULATORS OF ORPHAN NUCLEAR RECEPTOR RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORY, NR1F3) ACTIVITY AND FOR THE TREATMENT OF CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASES
申请人:Phenex Pharmaceuticals AG
公开号:EP2800745B1
公开(公告)日:2020-02-12
US9815851B2
申请人:——
公开号:US9815851B2
公开(公告)日:2017-11-14
Isomerization Accompanying the Acetylation of p-t-Butyltoluene